Oncotarget

Research Papers:

The overexpression of MDM4: an effective and novel predictor of gastric adenocarcinoma lymph node metastasis

Junjie Bao, Abiyasi Nanding, Haibin Song, Rui Xu, Guofan Qu and Yingwei Xue _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:67212-67222. https://doi.org/10.18632/oncotarget.11971

Metrics: PDF 1554 views  |   HTML 1386 views  |   ?  


Abstract

Junjie Bao1,2,*, Abiyasi Nanding3,*, Haibin Song1,*, Rui Xu4,*, Guofan Qu2, Yingwei Xue1

1Department of Gastroenterologic Surgery, Harbin Medical University Cancer Hospital, Harbin, China

2Department of Orthopedics, Harbin Medical University Cancer Hospital, Harbin, China

3Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China

4Department of Dermatology, Harbin Children’s Hospital, Harbin, China

*These authors contributed equally to this work

Correspondence to:

Yingwei Xue, email: xyw801@163.com

Guofan Qu, email: 67220591@qq.com

Keywords: MDM4, gastric adenocarcinoma, clinicopathological parameters, lymph node metastasis

Received: May 07, 2016     Accepted: September 02, 2016     Published: September 12, 2016

ABSTRACT

Background: MDM4 is the important negative regulator of the tumor suppressor protein p53, which is overexpressed in various human cancers. This study evaluates the MDM4 expression in patients with gastric adenocarcinoma (GTAC) at the mRNA and protein levels and examines relationships among MDM4 expression, clinicopathological features, and prognosis.

Results: The qRT-PCR and the Western blot analysis showed that the MDM4 expression level was high in GTACN+ but not in GTACN. The high expression level of MDM4 was significantly associated with age (P = 0.047), lymph node metastasis (LNM) (P < 0.001), pathological stage (P < 0.001), differentiation status (P = 0.001), and preoperative serum CA19-9 level (P < 0.001). Moreover, the survival analysis showed that Borrmann type, depth of invasion, LNM, and preoperative serum CA19-9 level were independent prognostic factors. The univariate analysis revealed that MDM4 expression influenced GTAC prognosis. Furthermore, the influence of overall prognosis relies on whether or not the high MDM4 expression level could lead to LNM.

Materials and Methods: We investigated MDM4 expression in primary GTAC and paired normal gastric tissues (30 pairs) through qRT-PCR and Western blot analyses. We also performed immunohistochemistry analysis on 336 paraffin-embedded GTAC specimens and 33 matched normal specimens.

Conclusions: MDM4 expression may result in LMN of GTAC. High MDM4 expression levels are associated with LMN of GTAC and influence the prognosis of patients with GTAC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 11971